Following fields are empty!
Welcome to the University of Turku Journal Guide
The Journal Guide gives you peace of mind when selecting journals. If you are a researcher from the University of Turku you can look up your favorite journals or search and filter to get to a selection of journals that match your research. Select a funder to see whether the journals are compliant or not, and check the filter ‘Journals with agreements’ to limit the list to journals for which the APCs are fully or partially waived.
Anti-Cancer Agents in Medicinal Chemistry
Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Anti-Cancer Drugs
Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion ja kustantajan välisen sopimuksen mukaan vastaavat kirjoittajat voivat julkaista artikkelinsa avoimena Lippincottin lehdissä sopimuskaudella 2024-2026 ilman avoimen julkaisemisen maksua (APC-maksu, Article Prosessing Charge). Maksuttomia avoimia artikkeleita on vuosittain käytössä rajattu määrä.According to the agreement between the FinELib consortium and the publisher, corresponding authors can publish their articles open access in Lippincott journals during the agreement period 2024-2026 without an article processing charge (APC). A limited number of free open access articles is available annually.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Lippincott lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Lippincott Journals
Anti-Corrosion Methods and Materials
ACMM provides practical research from around the world on the latest developments regarding the materials and techniques employed in corrosion prevention
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
List Price
Your Estimated Price (100% Discount)
Institutional Agreement
FinELib-konsortio on solminut Emeraldin kanssa vuosille 2025-2026 sopimuksen, johon sisältyy vastaaville kirjoittajille mahdollisuus julkaista artikkeleita avoimena Emerald Premier -lehdissä ilmaisilla open access -vouchereilla. Vouchereita on rajallinen määrä.FinELib consortium’s agreement with Emerald for the years 2025-2026 offers corresponding authors an opportunity to publish their articles with a free open access voucher. There's a limited number of vouchers available.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Emeraldin lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Emerald Journals
Anti-Infective Agents
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new anti-inflammatory & anti-allergy agents.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Anti-Trafficking Review
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antiarrhythmic effect of the Ca2+-activated K+ (SK) channel inhibitor ICA combined with either amiodarone or dofetilide in an isolated heart model of atrial fibrillation
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antibiotics
new antibiotics
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
Turun yliopiston affilioituneet tutkijat saavat sopimuskauden 1.3.2026-28.2.2027 aikana 10 %:n alennuksen MDPI:n julkaisemien lehtien APC-maksuista, sekä monografioiden BPC-maksuista. Kielen editointipalveluista kirjoittajat saavat 15 %:n alennuksen.As part of MDPI institutional open access program, University of Turku affiliated authors receive a 10 % discount on article processing charges (APCs) and on charges associated with open access book publishing with MDPI (BPCs) during the agreement period Mar 1, 2026 - Feb 28, 2027 . Authors will also receive 15 % discount on Language Editing Services.
- Ohjeita julkaisemiseen kustantajan sivuilla/Instructions on publishing on publisher's pages: Information for authors
Antibiotiki i Khimioterapiya
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antibodies
immunology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
Turun yliopiston affilioituneet tutkijat saavat sopimuskauden 1.3.2026-28.2.2027 aikana 10 %:n alennuksen MDPI:n julkaisemien lehtien APC-maksuista, sekä monografioiden BPC-maksuista. Kielen editointipalveluista kirjoittajat saavat 15 %:n alennuksen.As part of MDPI institutional open access program, University of Turku affiliated authors receive a 10 % discount on article processing charges (APCs) and on charges associated with open access book publishing with MDPI (BPCs) during the agreement period Mar 1, 2026 - Feb 28, 2027 . Authors will also receive 15 % discount on Language Editing Services.
- Ohjeita julkaisemiseen kustantajan sivuilla/Instructions on publishing on publisher's pages: Information for authors
Antibody Reports
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antibody Technology Journal
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antibody Therapeutics
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELibin ja Oxford University Pressin vuosille 2026-2028 neuvotteleman Read & Publish -sopimuksen ansiosta OUP:n täysin avoimissa (fully OA) lehdissä julkaistujen artikkeleiden kirjoittajamaksuista vastaavat kirjoittajat saavat 15% alennuksen.FinELib’s Read & Publish agreement with Oxford University Press for the years 2026-2028 allows corresponding authors from participating institutions to publish Open Access in OUP’s fully OA journals with a 15% discount of the APC (Article Processing Charge) list price.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Oxford University Pressin lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Oxford University Press Journals
Anticancer Research
The aim of the International Institute of Anticancer Research (IIAR) is to provide an independent platform for international cooperation in the fight against cancer. The IIAR will advance, protect and support throughout the world the ideals of freedom, peace, health, scientific knowledge, equality, welfare and mutual respect among communities in science and life.This site provides information on the aims and activities of the IIAR, including current cancer research projects and invitations for cooperation.The IIAR is supported by the three international peer-reviewed journals ANTICANCER RESEARCH, IN VIVO and CANCER GENOMICS & PROTEOMICS which are also available online through the Stanford University HighWire Press.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antichistica
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antichthon
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-sopimus kattaa sopimuskaudelle 2025-2026 Turun yliopistoon affilioituneille vastaaville kirjoittajille lisämaksuttoman ja rajoittamattoman avoimen julkaisemisen Cambridge University Pressin Full OA- ja hybridilehdissä.The FinELib agreement for 2025-2026 covers additional cost-free and unlimited open access publishing in Cambridge University Press Full OA and hybrid journals for corresponding authors affiliated to University of Turku.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Cambridge University Pressin lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Cambridge University Press Journals
- Koulutusaineistoja kirjoittajille/Training materials for authors:
- Welcome to Training Services for Cambridge Core
Antigua Matanza
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antiguo Oriente
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antiguos Jesuitas en Iberoamérica
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antigüedad y Cristianismo
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.